Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
NCT Number: NCT00267475
The purpose of this study is to conduct a translational study in patients with primary eosinophil associated gastrointestinal disorders [EGID] (e.g. eosinophilic esophagitis eosinophilic gastritis, eosinophilic enteritis [EE], eosinophilic colitis, and eosinophilic gastroenteritis [EGE]) with the aim of developing a data bank containing pertinent patient demographic information, tissue samples, and DNA, which will facilitate research on the pathophysiology of inflammatory disorders and the development of a verified successful clinical treatment program.
Looking for future studies?
Notify MeAll sexes
Observational
Cincinnati, Ohio, 45229-3039, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patients with an eosinophil associated gastrointestinal disorder (EGID), family members of patients with EGID, or normal controls.
Marc Rothenberg
Other
Clinical and Immunological Evaluation of Eosinophil Associated Gastrointestinal Disorders (EGID)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02897271
Digestive System Diseases, Eosinophilia
Little Rock, Arkansas, United States
View Trial DetailsNCT05199532
Digestive System Diseases, Eosinophilia
Chicago, Illinois, United States
View Trial DetailsNCT02523118
Digestive System Diseases, Eosinophilia
Phoenix, Arizona, United States
View Trial DetailsNCT00266565
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases
Cincinnati, Ohio, United States
View Trial Details